What is The Cooper Companies, Inc. (COO) stock price today?

The Cooper Companies, Inc. (COO) is currently trading at $54.30, down 0.82% today.

What is COO P/E ratio?

The Cooper Companies, Inc.'s P/E ratio is 19.29. This is near the market average.

What is COO return on equity (ROE)?

The Cooper Companies, Inc.'s return on equity (ROE) is 6.88%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is The Cooper Companies, Inc.'s market cap?

The Cooper Companies, Inc. has a market capitalization of $10.59B.

NASDAQ · Medical - Instruments & Supplies

The Cooper Companies, Inc. (COO) Stock

$54.30 -0.82% NASDAQ: COO Healthcare

Valuation

Metric	Value
Price	$54.30
Market Cap	$10.59B
P/E Ratio	19.29
P/B Ratio	1.31
P/S Ratio	2.60
EPS (TTM)	$0.00
52-Week High	$89.83
52-Week Low	$51.01
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	6.88%
ROA	4.50%
ROCE	5.04%
Gross Margin	64.24%
Operating Margin	17.19%
Net Margin	13.46%
Debt/Equity	0.31
Current Ratio	1.89

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.9B	$3.3B	$3.6B	$3.9B	$4.1B
Operating Profit	$506.0M	$508.0M	$533.0M	$706.0M	$683.0M
Net Profit	$2.9B	$386.0M	$294.0M	$392.0M	$375.0M
EPS	$14.79	$1.94	$1.48	$1.96	$1.87
Op Margin	17.3%	15.3%	14.8%	18.1%	16.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$9.6B	$11.5B	$11.7B	$12.3B	$12.4B
Total Liabilities	$2.7B	$4.3B	$4.1B	$4.2B	$4.2B
Cash	$96.0M	$138.0M	$121.0M	$108.0M	$111.0M
Borrowings	$1.5B	$2.8B	$2.6B	$2.6B	$2.8B

Latest News

COO: Lowering target price to $75.00 Argus Research · Jul 15, 2026 Goldman Sachs Adjusts Price Target on Cooper Companies to $63 From $66, Maintains Sell Rating MT Newswires · Jul 14, 2026 2 Momentum Stocks to Consider Right Now and 1 We Turn Down StockStory · Jul 3, 2026 CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure GlobeNewswire · Jun 30, 2026 How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks? Zacks · Jun 30, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$739.0M	$692.0M	$608.0M	$709.0M	$796.0M
Investing Cash Flow	$-665.0M	$-2.1B	$-841.0M	$-1.2B	$-735.0M
Financing Cash Flow	$-25.0M	$-98.0M	$-13.0M	$-30.0M	$-362.0M
Net Cash Flow	$-20.0M	$42.0M	$-18.0M	$-13.0M	$3.0M
Free Cash Flow	$524.0M	$450.0M	$215.0M	$288.0M	$434.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.44
EV / EBITDA	14.74
FCF Yield	6.15%
Quick Ratio	0.73
Interest Coverage	5.76
Return 1Y	-19.51%
Return 3Y	-27.99%
Return 5Y	-45.58%

Ownership

Insiders Held0.61%

Institutions Held106.74%

Institutions Float Held107.40%

Institutional Holder	Shares	Report Date
Blackrock Inc.	16,618,129	2026-03-31
Vanguard Capital Management LLC	12,718,829	2026-03-31
T. Rowe Price Investment Management, Inc.	9,060,177	2026-03-31
State Street Corporation	8,768,419	2026-03-31
Vanguard Portfolio Management LLC	8,721,331	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALCAlcon Inc.	$63.13	+0.21%	50.34	$30.79B	0.55%
BLCOBausch + Lomb Corporation	$17.15	-1.10%	-35.85	$6.13B	0.00%
ESLOYEssilorLuxottica S.A.	$98.62	-1.15%	31.71	$90.65B	2.35%
GKOSGlaukos Corporation	$161.29	-6.32%	-50.38	$9.51B	0.00%
HOCPFHOYA Corporation	$159.57	+0.00%	32.45	$53.38B	1.34%

About The Cooper Companies, Inc.

The Cooper Companies, Inc. is led by CEO Albert G. White, employs 15,000 people, headquartered in San Ramon, US, publicly traded since 1983.

The Cooper Companies, Inc. (COO) stock trades at $54.30 with a market capitalization of $10.59B. The stock is valued at a price-to-earnings (P/E) ratio of 19.29, price-to-book of 1.31, price-to-sales of 2.60. Over the past 52 weeks the stock has ranged between $51.01 and $89.83, and currently trades 39.6% below its 52-week high.

On profitability, The Cooper Companies, Inc. generates a return on equity (ROE) of 6.88%, return on capital employed of 5.04%, an operating margin of 17.19%, a net profit margin of 13.46%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1163.69 -0.51% JNJ Johnson & Johnson $255.86 -0.24% ABBV AbbVie Inc. $273.26 +0.31% MRK Merck & Company, Inc. Common Stock (new) $141.89 -0.34% UNH UnitedHealth Group Incorporated Common Stock (DE) $384.13 +3.55% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.66 +0.72% AMGN Amgen Inc. $406.05 -0.34% GILD Gilead Sciences, Inc. $147.20 +0.07% ABT Abbott Laboratories $98.92 +0.44% NVO Novo Nordisk A/S $38.18 -0.21%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides